Long-read single-cell genome, transcriptome and open chromatin profiling links genotype to phenotypes
Cancer is a heterogenous disease and current single-cell multiomic methods only provide limited genomic information. Here, the authors utilised single-cell Oxford Nanopore sequencing to investigate tumour evolution and why some cancer patients relapse after anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Using Oxford Nanopore sequencing, Pančíková, Cools, and Eftychiou et al. developed SPLONGGET, a custom workflow that simultaneously captures genomic, epigenomic, and transcriptomic information from individual cells. The authors applied this method to research samples isolated from a patient with leukaemia, revealing genetic changes linked to therapy resistance.
Watch Ruben Cools present this research at London Calling 2025
Sample type: bone marrow aspirates
